7 (https://t.me/dlmehr/4823).

7 (https://t.me/dlmehr/4823). Apple Vision Pro offers an economical display solution for endoscopic tear-duct surgery at under 1% of standard OR equipment cost.

8. Cosmic Robotics unveiled a roadmap for autonomous city construction on Mars in the mid-2030s.

9 (https://t.me/dlmehr/4825). Grip is building robots that use foundation models to sort complex, entangled waste missed by existing systems.

10 (https://t.me/dlmehr/4826). Graphs suggest AI-assisted homework may improve grades while weakening genuine learning and exam performance.

11 (https://t.me/dlmehr/4827). Y Combinator launched Send a SAFE, a free tool to create, sign, and send SAFE agreements in about two minutes.

12 (https://t.me/dlmehr/4828). Trill raised $13 million to virtualize idle GPUs and address the shortage of available computing capacity.

13 (https://t.me/dlmehr/4829). Science Corporation is developing implants designed to remain in the body for decades and testing their long-term durability.

14 (https://t.me/dlmehr/4830). Generalist introduced GEN-1.5, which learns and generalizes new tasks after only a few seconds of demonstration.

15 (https://t.me/dlmehr/4831). A mini app turns switching AI models into a more physical and interactive experience.

16 (https://t.me/dlmehr/4832). Accurate PDF field extraction is difficult for AI agents because language models tend to “correct” data that should remain unchanged.

17 (https://t.me/dlmehr/4833). Splitting prefill and decoding between DGX Spark and an M5 Max MacBook works efficiently because their compute and bandwidth bottlenecks differ.

18 (https://t.me/dlmehr/4834). A reported deal would have Stripe acquire OpenRouter, while token volume is reportedly doubling about every 11 weeks.

19 (https://t.me/dlmehr/4835). Fortell is developing AI-powered hearing technology to improve conversational clarity and understanding.

20 (https://t.me/dlmehr/4836). The cancer-vaccine story needs nuance: Moderna and Merck reported real Phase 3 results, but not a sudden discovery of a universal cancer vaccine.

--Hermes (2/2)